Search research articles
Contact Us
Filters
Showing results (1-10 of 25) with videos related to
Page
of 3
Sort By:
American Journal of Hematology
|
May 30, 2012
Lenalidomide in multiple myeloma: Current status and future potential
Hang Quach, Anna Kalff, Andrew Spencer
British Journal of Haematology
|
March 30, 2010
The impact of a regular erythrocytapheresis programme on the acute and chronic complications of sickle cell disease in adults
Anna Kalff, Claire Dowsing, Andrew Grigg
Cancer Biology & Medicine
|
July 27, 2016
Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies
Jay Hocking, Sridurga Mithraprabhu, Anna Kalff, et al.
Epigenetics
|
December 9, 2014
Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma
Sridurga Mithraprabhu, Anna Kalff, Annie Chow, et al.
Frontiers in Oncology
|
June 6, 2022
The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice
Rose Turner, Anna Kalff, Krystal Bergin, et al.
Heart & Lung : the Journal of Critical Care
|
May 22, 2018
Idiopathic systemic capillary leak syndrome presenting as septic shock: A case report
Eamon P Raith, Joshua F Ihle, Jennifer Jamieson, et al.
British Journal of Haematology
|
May 15, 2021
A phase II trial of continuous ixazomib, thalidomide and dexamethasone for relapsed and/or refractory multiple myeloma: the Australasian Myeloma Research Consortium (AMaRC) 16-02 trial
Krystal Bergin, Flora Yuen, Craig Wallington-Beddoe, et al.
Internal Medicine Journal
|
July 9, 2022
Upfront tandem autologous non-myeloablative allogeneic stem cell transplant in high-risk multiple myeloma: a long-term single-centre experience
Phillip C Nguyen, Jenny Muirhead, Joanne Tan, et al.
Bone Marrow Transplantation
|
December 2, 2020
Evaluation of EuroFlow minimal residual disease measurement and donor chimerism monitoring following tandem auto-allogeneic transplantation for multiple myeloma
Joanne L C Tan, Tongted Das, David Kliman, et al.
British Journal of Haematology
|
May 31, 2013
Central nervous system multiple myeloma--potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains
Denise Lee, Anna Kalff, Michael Low, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 25) with videos related to
Sort By:
Page
of 3
American Journal of Hematology
|
May 30, 2012
Lenalidomide in multiple myeloma: Current status and future potential
Hang Quach, Anna Kalff, Andrew Spencer
British Journal of Haematology
|
March 30, 2010
The impact of a regular erythrocytapheresis programme on the acute and chronic complications of sickle cell disease in adults
Anna Kalff, Claire Dowsing, Andrew Grigg
Cancer Biology & Medicine
|
July 27, 2016
Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies
Jay Hocking, Sridurga Mithraprabhu, Anna Kalff, et al.
Epigenetics
|
December 9, 2014
Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma
Sridurga Mithraprabhu, Anna Kalff, Annie Chow, et al.
Frontiers in Oncology
|
June 6, 2022
The Utility of Euroflow MRD Assessment in Real-World Multiple Myeloma Practice
Rose Turner, Anna Kalff, Krystal Bergin, et al.
Heart & Lung : the Journal of Critical Care
|
May 22, 2018
Idiopathic systemic capillary leak syndrome presenting as septic shock: A case report
Eamon P Raith, Joshua F Ihle, Jennifer Jamieson, et al.
British Journal of Haematology
|
May 15, 2021
A phase II trial of continuous ixazomib, thalidomide and dexamethasone for relapsed and/or refractory multiple myeloma: the Australasian Myeloma Research Consortium (AMaRC) 16-02 trial
Krystal Bergin, Flora Yuen, Craig Wallington-Beddoe, et al.
Internal Medicine Journal
|
July 9, 2022
Upfront tandem autologous non-myeloablative allogeneic stem cell transplant in high-risk multiple myeloma: a long-term single-centre experience
Phillip C Nguyen, Jenny Muirhead, Joanne Tan, et al.
Bone Marrow Transplantation
|
December 2, 2020
Evaluation of EuroFlow minimal residual disease measurement and donor chimerism monitoring following tandem auto-allogeneic transplantation for multiple myeloma
Joanne L C Tan, Tongted Das, David Kliman, et al.
British Journal of Haematology
|
May 31, 2013
Central nervous system multiple myeloma--potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains
Denise Lee, Anna Kalff, Michael Low, et al.
Page
of 3